**Question:** 4-year-old male child had febrile seizures, best prophylaxis –

A. Valproic acid
B. Phenobarbitone
C. Valacyclovir
D. Risperidone

**Core Concept:** Febrile seizures are common in young children, typically occurring within the first 6 years of life, and are often triggered by a fever. They are usually self-limiting and do not indicate underlying neurological problems.

**Why the Correct Answer is Right:**

The correct answer is **B. Phenobarbitone**. Phenobarbitone is a short-acting anticonvulsant medication that has been used for seizure prophylaxis in children with history of febrile seizures. It works by reducing the excitability of neurons and stabilizing the neuronal membrane potential. In the context of febrile seizures, its use helps to reduce the frequency of seizures in children with a family history of febrile seizures.

**Why Each Wrong Option is Incorrect:**

A. **Valproic acid (A)** is a broad-spectrum anticonvulsant used for various seizure types. However, its use in children with febrile seizures is controversial due to concerns about long-term developmental side effects. While it has been used in the past for prophylaxis, newer studies suggest that it may not be as effective as previously believed and may have more side effects.

C. **Valacyclovir (C)** is an antiviral drug primarily used for the treatment of herpes simplex virus infection and is not indicated for seizure prophylaxis in children with febrile seizures.

D. **Risperidone (D)** is an antipsychotic drug primarily used for the treatment of schizophrenia and other psychiatric disorders in adults. It is not recommended for children with febrile seizures due to its potential side effects, including weight gain, extrapyramidal symptoms, and an increased risk of diabetes and hyperlipidemia.

**Clinical Pearl:**

In the context of febrile seizures, it is essential to choose the appropriate medication with minimal side effects and long-term complications. Phenobarbitone is a suitable option due to its short half-life, making it easier to adjust the dosage and minimize the risk of side effects in children.

**Core Concept:** Febrile seizures are typically self-limiting events in children and do not indicate a need for prolonged anticonvulsant therapy. The choice of medication should be guided by the specific benefits and risks of each drug. In this scenario, phenobarbitone is chosen due to its favorable side effect profile and the need to minimize long-term complications in pediatric patients. The other options have limitations regarding their safety profile or therapeutic indication, making phenobarbitone the best choice.